Last reviewed · How we verify
NCT04669847
The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD
NA trial testing Trunk-oriented exercise program in Muscular Dystrophy, Duchenne in 26 participants. Completed in 6 December 2019.
1 April 2019
Quick facts
| Lead sponsor | Gokce Yagmur Gunes Gencer |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 7 April 2018 |
| Primary completion | 1 April 2019 |
| Estimated completion | 6 December 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Trunk-oriented exercise program
- Conventional exercise program
Conditions studied
- Muscular Dystrophy, Duchenne — all drugs for Muscular Dystrophy, Duchenne →
- Upper Extremity — all drugs for Upper Extremity →
- Respiratory Functions — all drugs for Respiratory Functions →
Sponsor
Gokce Yagmur Gunes Gencer
Who can join
Adults 5 to 16, male only, with Muscular Dystrophy, Duchenne or Upper Extremity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to investigate the effects of trunk training on trunk control, upper extremity, and pulmonary function in children with Duchenne muscular dystrophy (DMD). 26 children with DMD aged 5-16 were included in the study. They were divided into two groups (study and control). The study group exercised with the trunk-oriented exercise program and the conventional exercise program under the supervision of a physiotherapist, whereas the control group underwent the conventional exercise program under the supervision of their families at home for 8 weeks. Trunk control, the upper extremity function and respiratory function test were assessed before and after the 8-week exercise program in this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04669847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscular Dystrophy, Duchenne
Currently open trials in the same condition.
- NCT06833489 — Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases · NA · recruiting
- NCT06363357 — The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi · NA · recruiting
- NCT05066633 — The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients W · Phase 3 · recruiting
- NCT04626674 — A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in P · Phase 1 · recruiting
- NCT03992430 — A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04669847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gokce Yagmur Gunes Gencer
- Last refreshed: 17 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04669847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing